Zantac Lawsuit Signed Cases
Zantac is a medication used to prevent ulcers and acid reflux but a substance found in it may potentially cause cancer. The federal Food and Drug Administration (FDA) has stated a potentially cancer-causing chemical had been found at low levels in prescription and over-the-counter versions of Zantac. A naturally occurring but potentially cancer causing compound N-nitrosodimethylamine (NDMA) was discovered in low but “unacceptable” levels in random samples of the drug.
If your firm is interested in representing Zantac users who may have been injured by the drug, ZeroRisk Cases® can help. Our team is dedicated to providing the highest quality Zantac legal marketing services possible. Our mass tort case lead generation will find clients that fit your specific criteria.
The FDA and Health Canada issued public statements in September 2019 warning that since some medicines using ranitidine were found to contain NDMA, including over the counter Zantac, manufacturers should conduct additional testing, consumers should find alternatives and retailers should stop selling it. The maker of Zantac, France-based Sanofi, issued a voluntary recall of the drug a month later.
The company stated that evaluations of ranitidine, the drug’s active ingredient, and the finished product are ongoing, according to a company press release. Sanofi found “inconsistencies in preliminary test results of the active ingredient used in the U.S. and Canadian products” then decided to recall the over the counter version of the drug. Sanofi “encourages anyone using Zantac OTC to speak with their health care providers or pharmacists if they have any additional questions.”
Zantac, ranitidine, NDMA and cancer
Ranitidine in prescription drugs is used to treat ulcers to prevent them from returning after they healed. It’s also used to treat stomach and throat (esophagus) problems such as erosive esophagitis, gastroesophageal reflux disease-GERD and Zollinger-Ellison syndrome. It reduces the amount of acid produced in the stomach. Over the counter ranitidine products are used to prevent and treat heartburn and other symptoms caused by too much acid in the stomach (acid indigestion).
NDMA is found in industrial and natural processes. It’s classified by the federal Environmental Protection Agency as a probable carcinogen (something that causes cancer) because it modifies cells’ DNA, which can cause it to mutate. As time goes on and the mutations continue, cells can become cancerous. Pharmaceutical companies maintain that though NDMA has been shown in laboratory experiments to increase the risk of cancer in animals, there is no reliable evidence how much NDMA may increase the cancer risk in humans.
Unstable ingredient may poison Zantac users
CBS News found that the problem with Zantac and NDMA may not be a stray, inactive ingredient in the finished drug, like valsartan, but its active ingredient. At a lab in Connecticut, Valisure, researchers tested drugs from its online pharmacy to check for purity and quality. The over the counter version of Zantac stood out due to its high levels of NDMA.
Valisure CEO David Light stated the drug appeared to be a “fundamentally unstable molecule” that under various conditions in the lab and in the human body can form NDMA. The ranitidine/NDMA connection was first suggested three years ago in published research. Ten volunteers were given a Zantac tablet and their urine was tested afterward. It found NDMA levels more than 400 times greater than what the FDA considers acceptable.
How We Can Help Your Zantac Litigation Practice Grow
We focus our advertising efforts on TV, radio, organic SEO (Google, Bing, Yahoo), Google Maps, Google Ads, Bing, Facebook and Instagram, but depending on your ideal client profile, we may turn to other platforms. Unlike other mass tort ad agencies, we have experience with a number of different ad platforms, so we can use just the right one to get the job done. We focus on mobile marketing, utilizing Voice Search, to capture some of the best and highest converting leads.
We also use remarketing and behavioral targeting in our lead generation campaigns. Remarketing and behavioral targeting allow us to target the right people at the right time with the right message to get them on the phone.
Our latest technology utilizes our proprietary software that enables us to data mine information through third party vendors, resulting in cases where leads have been matched with their medical histories, diagnosis, drug prescription and treatments with exposure or usage of a caustic drug or chemical. This significantly reduces the cost of acquisition and provides a much higher value clients; one that has proof of usage or exposure; proof of diagnosis; and proof of treatment.
Get started before your competitors do. There’s only so many clients we can serve.
CONTACT US FOR A CUSTOM QUOTE.
CALL 833-937-6747 OR USE OUR REQUEST A QUOTE FORM.